Engage, learn, and connect from anywhere in the world. We invite you to explore the focused event pages as well as the full calendar of upcoming events.
Do a little or do a lot. Leverage JAX expertise to generate in vivo data on your cutting-edge antibody, small molecule, or cell therapy treatment using the platform best suited for your research needs.
Start your expedition by exploring our model access, tailored characterization, and preclinical in vivo solution options through a variety of resources including livestreams, webinars, and more!
JAX is a resource for you regardless of where you are in your drug discovery pipeline. Not only do we offer the largest collection of neurological mutants available in the world, we offer a wide variety of preclinical services for many common models of neurological disorders.
Include Past 6 Months
Su | M | Tu | W | Th | F | Sa |
|---|---|---|---|---|---|---|
1 |
2 |
3 |
4 |
|||
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
16 |
17 |
18 |
19 |
20 |
21 |
22 |
23 |
24 |
25 |
26 |
27 |
28 |
29 |
30 |
31 |
Su | M | Tu | W | Th | F | Sa |
|---|---|---|---|---|---|---|
1 |
||||||
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
16 |
17 |
18 |
19 |
20 |
21 |
22 |
23 |
24 |
25 |
26 |
27 |
28 |
29 |
30 |
31 |
Su | M | Tu | W | Th | F | Sa |
|---|---|---|---|---|---|---|
1 |
2 |
3 |
4 |
5 |
||
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
16 |
17 |
18 |
19 |
20 |
21 |
22 |
23 |
24 |
25 |
26 |
27 |
28 |
29 |
30 |
Su | M | Tu | W | Th | F | Sa |
|---|---|---|---|---|---|---|
1 |
2 |
3 |
||||
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
16 |
17 |
18 |
19 |
20 |
21 |
22 |
23 |
24 |
25 |
26 |
27 |
28 |
29 |
30 |
31 |
Su | M | Tu | W | Th | F | Sa |
|---|---|---|---|---|---|---|
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
16 |
17 |
18 |
19 |
20 |
21 |
22 |
23 |
24 |
25 |
26 |
27 |
28 |
29 |
30 |
Su | M | Tu | W | Th | F | Sa |
|---|---|---|---|---|---|---|
1 |
2 |
3 |
4 |
5 |
6 |
|
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
16 |
17 |
18 |
19 |
20 |
21 |
22 |
23 |
24 |
25 |
26 |
27 |
28 |
29 |
30 |
31 |
Su | M | Tu | W | Th | F | Sa |
|---|---|---|---|---|---|---|
1 |
2 |
3 |
||||
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
16 |
17 |
18 |
19 |
20 |
21 |
22 |
23 |
24 |
25 |
26 |
27 |
28 |
29 |
30 |
Su | M | Tu | W | Th | F | Sa |
|---|---|---|---|---|---|---|
1 |
2 |
3 |
||||
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
16 |
17 |
18 |
19 |
20 |
21 |
22 |
23 |
24 |
25 |
26 |
27 |
28 |
29 |
30 |
31 |
Su | M | Tu | W | Th | F | Sa |
|---|---|---|---|---|---|---|
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
16 |
17 |
18 |
19 |
20 |
21 |
22 |
23 |
24 |
25 |
26 |
27 |
28 |
29 |
30 |
31 |
Su | M | Tu | W | Th | F | Sa |
|---|---|---|---|---|---|---|
1 |
2 |
3 |
4 |
|||
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
16 |
17 |
18 |
19 |
20 |
21 |
22 |
23 |
24 |
25 |
26 |
27 |
28 |
29 |
30 |
Su | M | Tu | W | Th | F | Sa |
|---|---|---|---|---|---|---|
1 |
2 |
3 |
4 |
5 |
6 |
|
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
16 |
17 |
18 |
19 |
20 |
21 |
22 |
23 |
24 |
25 |
26 |
27 |
28 |
29 |
30 |
We use cookies to personalize our website and to analyze web traffic to improve the user experience. You may decline these cookies although certain areas of the site may not function without them. Please refer to our privacy policy for more information.